Results 131 to 140 of about 28,367 (198)

Quality of life outcomes and patient-reported experiences in a randomised controlled trial for rifampicin-resistant TB (PRACTECAL-PRO): a mixed-methods study. [PDF]

IJTLD Open
Lowton K, Stringer B, Cusinato M, Fielding K, Liverko I, Moodliar R, Nikolaevna TZ, Solodovnikova V, Kazounis E, Nyang'wa BT.   +9 more
europepmc   +1 more source

Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin: Mechanisms of Action, Drug Interactions, Adverse Effects and Use in Special Situations. [PDF]

Microorganisms
Arbex MA.
europepmc   +1 more source

Combating Drug Resistance in <i>Mycobacterium Tuberculosis</i>: A Combinatorial in Silico and Experimental Modeling Approach Toward Novel ATP Synthase Inhibitor Discovery. [PDF]

Bioinform Biol Insights
El-Zoheiry HH, Bhowmik R, Manaithiya A, Ray R, Samantaray M, Ramaswamy A, Aspatwar A.   +6 more
europepmc   +1 more source

Metabolic perturbation reduces antibiotic tolerance in <i>Mycobacterium tuberculosis</i>. [PDF]

Microbiology (Reading)
Cheung CY, Samuels I, Klaus HR, Cook GM, McNeil MB.   +4 more
europepmc   +1 more source

A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2026 Update for Clinicians and Scientists. [PDF]

Pathog Immun
Tunesi S, Bothamley G, Günther G, Kherabi Y, Kuksa L, Lange B, Lange C, Lorent N, Saluzzo F, Sester M, Iversen XES, Tebruegge M, Tweed C, Vasiliu A, Guglielmetti L, Tuberculosis Network European Trials group (TBnet).   +15 more
europepmc   +1 more source

Interim Effectiveness and Safety of Prolonged Bedaquiline Use in Comparison to Standard 24-Week Treatment for MDR-TB: A Multicenter Cohort Study in China. [PDF]

Infect Drug Resist
Hu X, Gao M, Liu Y, Pei Y, Du J, Wu G, Wang A, Li L, Gao J.   +8 more
europepmc   +1 more source

A scoping review of interventions in childhood tuberculosis prevention and treatment. [PDF]

Public Health Pract (Oxf)
Rahaman MZ, Alam T, Nahar SS, Nahrin R, Bushra IJ, Ahmed S, Banu S, Shahrin L.   +7 more
europepmc   +1 more source

Multidrug-resistant tuberculosis (MDR-TB) in people living with HIV: Clinical issues, therapeutic challenges and perspectives in sub-Saharan Africa. A narrative review. [PDF]

J Clin Tuberc Other Mycobact Dis
Tague C.
europepmc   +1 more source

The Peak Plasma Concentration (Cmax)/Minimum Inhibitory Concentration (MIC) of bedaquiline and levofloxacin with special attention to the sputum conversion in the treatment of multidrug-resistant tuberculosis in Indonesia. [PDF]

PLoS One
Mariana N, Gayatri A, Widyahening IS, Bela B, Soedarsono S, Maemunah I, Rosamarlina R, Setiawaty V, Myneedu VP, Nelwan EJ, Ascobat P.   +10 more
europepmc   +1 more source

Rifampicin-resistant TB in paediatrics: a patient series from a secondary health facility in Northern Malawi. [PDF]

Public Health Action
Chitsulo S, Omotayo D, Furin J, Saidi Y, Chisale M, Mbakaya B, Sinyiza F, Mwenyenkulu T.   +7 more
europepmc   +1 more source